C4 THERAPEUTICS INC filings

SEC filings by C4 THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G2024-04-10STATE STREET CORPC4 Therapeutics, Inc.-10.4%EDGAR
SC 13G/A2024-03-08WASATCH ADVISORS LPC4 Therapeutics, Inc.--EDGAR
SC 13G/A2024-02-14PRICE T ROWE ASSOCIATES INC /MD/C4 Therapeutics, Inc.2,558,4805.2%EDGAR
SC 13G/A2024-02-14RTW INVESTMENTS, LPC4 Therapeutics, Inc.00.0%EDGAR
SC 13G/A2024-02-14Lynx1 Capital Management LPC4 Therapeutics, Inc.3,134,3966.4%EDGAR
SC 13G/A2024-02-09WASATCH ADVISORS LPC4 Therapeutics, Inc.--EDGAR
SC 13G2024-02-05Soleus Capital Master Fund, L.P.C4 Therapeutics, Inc.2,555,9965.2%EDGAR
SC 13G/A2024-02-02Soleus Capital Master Fund, L.P.C4 Therapeutics, Inc.1,835,9963.7%EDGAR
SC 13G2024-01-12Betta Investment (Hong Kong) Ltd.C4 Therapeutics, Inc.5,567,9288.1%EDGAR
SC 13G2024-01-04Point72 Asset Management, L.P.C4 Therapeutics, Inc.2,312,0594.7%EDGAR
SC 13G2023-12-26RA CAPITAL MANAGEMENT, L.P.C4 Therapeutics, Inc.4,878,0009.9%EDGAR
SC 13G2023-12-22COMMODORE CAPITAL LPC4 Therapeutics, Inc.3,800,0007.7%EDGAR
SC 13G2023-11-13Lynx1 Capital Management LPC4 Therapeutics, Inc.3,122,2196.3%EDGAR
SC 13G2023-07-25MILLENNIUM MANAGEMENT LLCC4 Therapeutics, Inc.2,370,5044.8%EDGAR
SC 13G/A2023-07-07BlackRock Inc.C4 Therapeutics, Inc.2,086,5634.3%EDGAR
SC 13G/A2023-06-12ArrowMark Colorado Holdings LLCC4 Therapeutics, Inc.1,493,4503.0%EDGAR
SC 13G2023-04-14Soleus Capital Master Fund, L.P.C4 Therapeutics, Inc.2,462,0205.0%EDGAR
SC 13G/A2023-02-14PRICE T ROWE ASSOCIATES INC /MD/C4 Therapeutics, Inc.2,925,2536.0%EDGAR
SC 13G/A2023-02-14RTW INVESTMENTS, LPC4 Therapeutics, Inc.2,819,4725.8%EDGAR
SC 13G2023-02-14ArrowMark Colorado Holdings LLCC4 Therapeutics, Inc.5,802,87111.8%EDGAR